Table 4.
Variable | Score | Deaths (n = 18)† | Survivals (n = 53)† | p Value |
---|---|---|---|---|
C-reactive protein, mg/L | 61.28 | 92.26 | ||
< 150 | 0 | 18 | 43 | 0.04* |
≥ 150 | 4 | 0 | 10 | |
Total leukocyte count, cells/mm3 | 7.266 | 13.114 | ||
< 15 | 0 | 16 | 32 | |
15–25 | 1 | 2 | 21 | 0.02* |
> 25 | 2 | 0 | 0 | |
Hemoglobin, g/dL | 12.74 | 12.68 | ||
> 13.5 | 0 | 8 | 20 | |
11–13.5 | 1 | 8 | 22 | 0.3 |
< 11 | 2 | 2 | 11 | |
Sodium, mmol/L | 137.5 | 137.1 | ||
> 135 | 0 | 14 | 42 | 0.5 |
< 135 | 2 | 4 | 11 | |
Creatinine, umol/L | 188.33 | 144.62 | ||
≤ 141 | 0 | 10 | 34 | 0.35 |
> 141 | 2 | 8 | 19 | |
Glucose, mmol/L | 8.29 | 8.47 | ||
≤ 10 | 0 | 13 | 38 | 0.61 |
> 10 | 1 | 5 | 15 | |
Total score (mean) | 2.44 | 3.3 | ||
> 6 | 0 | 8 | 0.08 | |
< 6 | 18 | 45 |
*Mean p < 0.05 and the difference was significant; †one male patient survived the first episode but died after the second episode, therefore his data are include in the death and survival categories here.